PMS20 - BUDGET IMPACT OF INTRODUCING SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1734
https://www.valueinhealthjournal.com/article/S1098-3015(18)35036-8/fulltext
Title :
PMS20 - BUDGET IMPACT OF INTRODUCING SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35036-8&doi=10.1016/j.jval.2018.09.1734
First page :
Section Title :
Open access? :
No
Section Order :
1100